These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Epigenetic inactivation of DNA repair in breast cancer. Nowsheen S; Aziz K; Tran PT; Gorgoulis VG; Yang ES; Georgakilas AG Cancer Lett; 2014 Jan; 342(2):213-22. PubMed ID: 22634493 [TBL] [Abstract][Full Text] [Related]
5. Epigenetic biomarkers in lung cancer. Liloglou T; Bediaga NG; Brown BR; Field JK; Davies MP Cancer Lett; 2014 Jan; 342(2):200-12. PubMed ID: 22546286 [TBL] [Abstract][Full Text] [Related]
6. Road to early detection of pancreatic cancer: Attempts to utilize epigenetic biomarkers. Fukushige S; Horii A Cancer Lett; 2014 Jan; 342(2):231-7. PubMed ID: 22450751 [TBL] [Abstract][Full Text] [Related]
7. Epigenetic biomarkers of colorectal cancer: Focus on DNA methylation. Coppedè F Cancer Lett; 2014 Jan; 342(2):238-47. PubMed ID: 22202641 [TBL] [Abstract][Full Text] [Related]
8. Glioma epigenetics: From subclassification to novel treatment options. Gusyatiner O; Hegi ME Semin Cancer Biol; 2018 Aug; 51():50-58. PubMed ID: 29170066 [TBL] [Abstract][Full Text] [Related]
9. Global histone modification patterns as prognostic markers to classify glioma patients. Liu BL; Cheng JX; Zhang X; Wang R; Zhang W; Lin H; Xiao X; Cai S; Chen XY; Cheng H Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2888-96. PubMed ID: 20978174 [TBL] [Abstract][Full Text] [Related]
12. Epigenetic changes in gliomas. Burgess R; Jenkins R; Zhang Z Cancer Biol Ther; 2008 Sep; 7(9):1326-34. PubMed ID: 18836290 [TBL] [Abstract][Full Text] [Related]
13. Feedback networks between microRNAs and epigenetic modifications in urological tumors. Liep J; Rabien A; Jung K Epigenetics; 2012 Apr; 7(4):315-25. PubMed ID: 22414795 [TBL] [Abstract][Full Text] [Related]
14. Epigenetic markers in human gliomas: prospects for therapeutic intervention. Hesson LB; Krex D; Latif F Expert Rev Neurother; 2008 Oct; 8(10):1475-96. PubMed ID: 18928342 [TBL] [Abstract][Full Text] [Related]
15. Neuropathological and molecular aspects of low-grade and high-grade gliomas. Michotte A; Neyns B; Chaskis C; Sadones J; In 't Veld P Acta Neurol Belg; 2004 Dec; 104(4):148-53. PubMed ID: 15742604 [TBL] [Abstract][Full Text] [Related]
16. Cancer epigenetics as biomarkers of clinical significance. Panayiotidis MI Cancer Lett; 2014 Jan; 342(2):168-9. PubMed ID: 24183850 [No Abstract] [Full Text] [Related]
18. Epigenetic aberrations in malignant gliomas: an open door leading to better understanding and treatment. Martinez R; Schackert G Epigenetics; 2007; 2(3):147-50. PubMed ID: 18063907 [TBL] [Abstract][Full Text] [Related]
19. Cancer epigenetics. Taby R; Issa JP CA Cancer J Clin; 2010; 60(6):376-92. PubMed ID: 20959400 [TBL] [Abstract][Full Text] [Related]
20. DNA methylation and histone modifications in patients with cancer: potential prognostic and therapeutic targets. Herranz M; Esteller M Methods Mol Biol; 2007; 361():25-62. PubMed ID: 17172706 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]